Premium
Effect of controlled release of fibroblast growth factor‐2 from chitosan/fucoidan micro complex‐hydrogel on in vitro and in vivo vascularization
Author(s) -
Nakamura Shingo,
Nambu Masaki,
Ishizuka Takamitsu,
Hattori Hidemi,
Kanatani Yasuhiro,
Takase Bonpei,
Kishimoto Satoko,
Amano Yoshiko,
Aoki Hiroshi,
Kiyosawa Tomoharu,
Ishihara Masayuki,
Maehara Tadaaki
Publication year - 2007
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.31563
Subject(s) - fucoidan , chitosan , fibroblast growth factor , in vivo , materials science , fibroblast , in vitro , biophysics , self healing hydrogels , biochemistry , chemistry , polysaccharide , biology , polymer chemistry , receptor , microbiology and biotechnology
We produced a chitosan/fucoidan micro complex‐hydrogel as a carrier for controlled release of heparin binding growth factors such as fibroblast growth factor (FGF)‐2. Material consisting of a soluble chitosan (CH‐LA) mixed with fucoidan yielded a water‐insoluble and injectable hydrogel with filamentous particles. In this study, we examined the ability of the chitosan/fucoidan complex‐hydrogel to immobilize FGF‐2 and to protect its activity, as well as the controlled release of FGF‐2 molecules. The chitosan/fucoidan complex‐hydrogel has high affinity for FGF‐2 ( K d = 5.4 × 10 − 9 M ). The interaction of FGF‐2 with chitosan/fucoidan complex‐hydrogel substantially prolonged the biological half‐life time of FGF‐2. It also protected FGF‐2 from inactivation, for example by heat and proteolysis, and enhance FGF‐2 activity. When FGF‐2‐containing complex‐hydrogel was subcutaneously injected into the back of mice, significant neovascularization and fibrous tissue formation were induced near the site of injection at 1 week, and the complex‐hydrogel was biodegraded and disappeared by 4 weeks. These findings indicate that controlled release of biologically active FGF‐2 molecules is caused by both slow diffusion and biodegradation of the complex‐hydrogel, and that subsequent induction of vascularization occurs. FGF‐2‐containing chitosan/fucoidan micro complex‐hydrogel is thus useful and convenient for treatment of ischemic disease. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008